Borderline Personality Disorder research hub
9 indexed studies · 5 currently recruiting
- active not recruitingNA
Testing an Alliance-Focused Dialectical Behaviour Therapy Training for Borderline Personality Disorder
This study is testing new ways to train therapists to better help people with Borderline Personality Disorder (BPD). It focuses on improving how therapists connect with their patients, especially when things get difficult, to make therapy more effective.
Canada - authorisedTherapeutic exploratory (Phase II)
A phase II, double-blinded, placebo-controlled, clinical trial to determine the efficacy and safety of AP707 in the treatment of Borderline Personality Disorder.
This study is testing a new medication called AP707 for people with Borderline Personality Disorder. Researchers want to see if AP707 helps improve symptoms and if it's safe to use, compared to a dummy pill (placebo).
Germany - recruitingPHASE1
A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperactivity Disorder
This study is testing a new medicine, BI 3031185, for people with Borderline Personality Disorder (BPD) or Attention Deficit Hyperactivity Disorder (ADHD). It wants to understand how adults with these conditions react to the medication and if it causes any unwanted effects.
Germany - recruitingPHASE1, PHASE2
Brain Signal Training to Enhance Affect Down-regulation
This study looks at a new training called 'neurofeedback' for people with Borderline Personality Disorder (BPD). It aims to help them learn to control strong negative emotions, potentially reducing emotional ups and downs. Researchers want to see if this brain training really helps.
Germany - recruitingNA
Evaluation of a Dimensional Adaptation of Good Psychiatric Management (GPM-extended) for the Treatment of Borderline Personality Disorder
This study compares two ways of managing Borderline Personality Disorder (BPD): GPM-extended and classic GPM. It wants to see if GPM-extended, which is more personalised, works better at reducing BPD symptoms and improving daily life for adults over one year.
France - recruitingNA
Short Integrative And Neurocognitive Therapy For Young Adults With Borderline Personality Disorder
This study is testing a new, shorter therapy called SINTYA for young adults (16-25) with Borderline Personality Disorder (BPD). It aims to see if this therapy can reduce impulsive behaviours and other symptoms, improving how they manage daily life.
France - recruitingNA
Impulsivity With Borderline Personality Disorder/tMS
This study is looking into a new brain stimulation treatment for people with Borderline Personality Disorder (BPD) to help reduce impulsivity. It compares two types of this stimulation to see if one is more effective.
France - authorisedTherapeutic exploratory (Phase II)
Ketamine infusion for symptomatological improvement of severe borderline personality disorder: a pilot study
This study is looking at whether a specific dose of ketamine, delivered as an infusion, can help improve severe symptoms in adults with Borderline Personality Disorder (BPD). It's a small, early-stage study to see if this treatment might be helpful.
France - recruitingPhase III
Quetiapine effectiveness study in borderline personality disorder (QUEST)
This study looks at whether the drug quetiapine helps people with Borderline Personality Disorder (BPD). Participants will receive either quetiapine or a dummy pill for 12 months, alongside their usual care, to see if it improves symptoms and offers good value for money.
United Kingdom · England